the age , gender , left ventricular ejection fraction , baseline right ventricular effective refractory period , baseline hv interval , and baseline ventricular tachycardia cycle length were not predictive of ventricular tachycardia suppression with intravenous procainamide or quinidine during programmed ventricular stimulation .
C0042514
ventricular tachycardia
C0033216
procainamide